Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Determination of Absorptivity Values – V 2.0

Posted on By

Analytical Method Development: Determination of Absorptivity Values – V 2.0

SOP for Determination of Absorptivity Values in UV Spectrophotometry


Department Analytical Method Development
SOP No. SOP/AMD/092/2025
Supersedes SOP/AMD/092/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for determining the absorptivity value (A 1%, 1cm) of Active Pharmaceutical Ingredients (APIs) using UV spectrophotometry, ensuring method standardization, reproducibility, and regulatory compliance with USP and ICH guidelines.

2. Scope

This procedure is applicable to the Analytical Method Development (AMD) department for the determination of absorptivity values of APIs and reference standards used in pharmaceutical formulation and quality control.

3. Responsibilities

  • Analytical Chemist: Prepares dilutions, performs UV scans, calculates absorptivity values.
  • Reviewer: Validates accuracy of calculations and spectrophotometric readings.
  • QA Officer: Ensures adherence to documentation practices and compliance with regulations.
  • Head – AMD: Approves determined absorptivity values and ensures SOP compliance.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that absorptivity values determined using this procedure are scientifically justified, reproducible, and suitable for regulatory submissions and specification building.

See also  Analytical Method Development: SOP for Analytical Method for Creams and Gels - V 2.0

5. Procedure

5.1 Principle

  1. Absorptivity (A 1%, 1cm) is the absorbance of a 1% w/v solution in a 1 cm path length cuvette.
  2. Calculated using:
    A (1%, 1cm) = (A × 100) / C
    

    Where:

    • A = absorbance of test solution
    • C = concentration in mg/mL

5.2 Selection of Wavelength (λmax)

  1. Scan test solution from 200–400 nm using UV spectrophotometer.
  2. Determine wavelength with highest and stable absorbance (λmax).
  3. Confirm absence of interference from solvent or excipients.
  4. Document in Annexure-1: Wavelength Scanning Report.

5.3 Standard Solution Preparation

  1. Accurately weigh 100 mg of API or reference standard.
  2. Dissolve in solvent (e.g., water, ethanol, methanol) and make up to 100 mL volume to achieve 1 mg/mL (0.1% w/v).
  3. Further dilute to 0.01% w/v (100 µg/mL) if absorbance exceeds 1.0.
  4. Use matched quartz cuvettes and record absorbance at λmax.
  5. Record in Annexure-2: Standard Preparation Log.

5.4 Blank and Instrument Setup

  1. Use blank solvent (same as used for sample) in reference cell.
  2. Use spectrophotometer set to 1 nm bandwidth and 1.000 path length (cm).
  3. Zero instrument with blank before taking absorbance of test solution.
  4. Confirm baseline stability and document in Annexure-3: Blank Verification Log.
See also  Analytical Method Development: Aseptic Technique SOP for AMD - V 2.0

5.5 Calculation of Absorptivity Value

  1. Use following formula:
    A (1%, 1cm) = (Absorbance × 100) / Concentration in mg/mL
    
  2. Example: Absorbance = 0.875 at 260 nm; Concentration = 0.01 mg/mL (0.001% w/v)
    A (1%, 1cm) = (0.875 × 100) / 0.01 = 8750
  3. Repeat with at least three concentrations to ensure linearity.
  4. Record in Annexure-4: Absorptivity Calculation Sheet.

5.6 Verification of Linearity and Precision

  1. Prepare three dilutions (e.g., 80, 100, 120 µg/mL).
  2. Measure absorbance and calculate A (1%, 1cm) for each.
  3. Acceptance Criteria:
    • %RSD of A (1%, 1cm) ≤ 2.0%
    • Linearity: R² ≥ 0.995
  4. Document in Annexure-5: Linearity and Precision Report.

5.7 Application in Assay and Dissolution

  1. Use A (1%, 1cm) value to convert absorbance to concentration for:
    • Single-point assay
    • Routine dissolution testing
    • Analytical method equivalency checks
  2. Ensure that same solvent, cuvette, and path length are used in all subsequent applications.

6. Abbreviations

  • UV: Ultraviolet
  • API: Active Pharmaceutical Ingredient
  • λmax: Wavelength of Maximum Absorbance
  • A (1%, 1cm): Absorptivity of 1% solution in 1 cm cell
  • RSD: Relative Standard Deviation

7. Documents

  1. Wavelength Scanning Report – Annexure-1
  2. Standard Preparation Log – Annexure-2
  3. Blank Verification Log – Annexure-3
  4. Absorptivity Calculation Sheet – Annexure-4
  5. Linearity and Precision Report – Annexure-5
See also  Analytical Method Development: SOP for Content Uniformity Method for Ointments - V 2.0

8. References

  • USP <857> – Ultraviolet-Visible Spectroscopy
  • ICH Q2(R1) – Validation of Analytical Procedures
  • Ph. Eur. and IP Monographs on UV Absorptivity
  • FDA Guidance on Analytical Methods

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Wavelength Scanning Report

Sample ID Solvent Scan Range λmax (nm)
API-UV-212 Methanol 200–400 nm 262

Annexure-2: Standard Preparation Log

Substance Weight (mg) Solvent Volume (mL) Prepared By
API-212 100.0 Methanol 100 Sunita Reddy

Annexure-3: Blank Verification Log

Blank Solvent Absorbance at λmax Conclusion
Methanol 0.001 No Interference

Annexure-4: Absorptivity Calculation Sheet

Sample Concentration (mg/mL) Absorbance A (1%, 1cm)
API-212 0.01 0.853 8530

Annexure-5: Linearity and Precision Report

Concentration (µg/mL) Absorbance A (1%, 1cm)
80 0.682 8525
100 0.853 8530
120 1.021 8517

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Annexures expanded to include linearity and blank interference Annual SOP Update
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Creams: SOP for Sampling and Testing Bulk Creams before Filling – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Formulation Development of Intravenous Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version